Physician

Alyse Richard, M.D.

According to 2025 Medicare claims, Alyse Richard, M.D. (NPI: 1629428701) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is EYE HEALTH ASSOCIATES INC (NPI: 1952653131; TIN: 461083116) and primary practice location at 02747-3319.

Richard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 704 traditional Medicare patients, billed 6,518 HCPCS/CPT codes, and received $459,826 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,158 prescription claims across 488 beneficiaries totaling $173,899 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 10 records totaling $224. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,097 to $459,826. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,702 to $173,899. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$283K$565K2020 Medicare payment: $5,097 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $50,151 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $327,284 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $565,386 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $459,826 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20202960$5,097
2021242533$50,151
20226253,298$327,284
20237765,368$565,386
20247046,518$459,826

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$113K$225K2016 Drug cost: $2,702 (USD; Tot_Drug_Cst)2017 Drug cost: $3,246 (USD; Tot_Drug_Cst)2018 Drug cost: $16,367 (USD; Tot_Drug_Cst)2019 Drug cost: $15,997 (USD; Tot_Drug_Cst)2020 Drug cost: $13,897 (USD; Tot_Drug_Cst)2021 Drug cost: $29,543 (USD; Tot_Drug_Cst)2022 Drug cost: $163,410 (USD; Tot_Drug_Cst)2023 Drug cost: $225,499 (USD; Tot_Drug_Cst)2024 Drug cost: $173,899 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20163573$2,702
201772126$3,246
2018104294$16,367
2019132375$15,997
2020106329$13,897
2021109267$29,543
20224902,203$163,410
20236252,908$225,499
20244882,158$173,899

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system564749$82
92134Imaging of retina368509$29
92136Measurement of corneal curvature and depth of eye141278$27
92025Ct scan of cornea168215$25
92202Extended exam of the back part of the eye with optic nerve drawing236294$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine361,680$34,027
XiidraLifitegrast141,020$22,428
CequaCyclosporine151,170$21,489
LumiganBimatoprost532,177$20,844
Prednisolone AcetatePrednisolone Acetate46810,185$13,274

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$224SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alyse Richard, M.D.?

Tedicare shows public-source Medicare data for Alyse Richard, M.D. (NPI 1629428701), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alyse Richard, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alyse Richard, M.D.?

Alyse Richard, M.D. is linked to EYE HEALTH ASSOCIATES INC (billing NPI 1952653131) in the available physician profile data.

Does Alyse Richard, M.D. have Open Payments data?

Alyse Richard, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.